Ignite Creation Date:
2024-05-06 @ 12:44 AM
Last Modification Date:
2024-10-26 @ 10:54 AM
Study NCT ID:
NCT01648192
Status:
COMPLETED
Last Update Posted:
2017-07-26
First Post:
2012-07-12
Brief Title:
Phase I Study of GW856553 Losmapimod
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07-24
Start Date Type:
ACTUAL
Primary Completion Date:
2012-10-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10-26
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-12
First Submit QC Date:
July 19 2012
Study First Post Date:
2012-07-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-24
Last Update Post Date:
2017-07-26
Last Update Post Date Type:
ACTUAL